Form 4: Rachesky Reports Lionsgate Studios Corp. Share Transactions

Mark H. Rachesky, M.D. reports significant transactions in Lionsgate Studios Corp. common shares, including acquisitions and dispositions.

Summary

• Mark H. Rachesky, M.D., a Director and 10% Owner of Lionsgate Studios Corp. (LION), has filed a Form 4 detailing numerous transactions of common shares on July 8, 2026.
• These transactions include both the acquisition (A) and disposition (S) of substantial blocks of common shares across various investment entities managed by MHR Fund Management LLC.
• The filing outlines the beneficial ownership of Rachesky through multiple limited partnerships and limited liability companies, with disclaimers of beneficial ownership except to the extent of pecuniary interest.
• Specific transactions include the disposition of 1,469,450 shares, 3,701,988 shares, and 25,173,882 shares, alongside acquisitions of 797,526 shares, 1,916,271 shares, 11,154,680 shares, 671,924 shares, 499,765 shares, 15,804,919 shares, and 11,755,412 shares.
• The reporting person also acquired 499,765 shares and disposed of 499,765 shares in a separate transaction.
• Footnotes detail that these transactions are in connection with a 'continuation fund transaction' (CV Transaction) involving contributions of common shares to new entities in exchange for partnership interests.
• The filing also notes that the reported shares do not include those potentially beneficially owned due to a Voting and Standstill Agreement and a Governance, Standstill and Voting Agreement with Liberty Global entities and Liberty 77 Capital entities, as the reporting persons have no pecuniary interest in those shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it details routine insider transactions related to fund management and restructuring, rather than a direct reflection of the company's operational performance or future prospects.

Positives

• Mark H. Rachesky, M.D. acquired a significant number of Lionsgate Studios Corp. common shares across multiple transactions, indicating continued investment or strategic repositioning.
• The transactions are part of a 'continuation fund transaction' which may represent a strategic restructuring or recapitalization for the benefit of investors.
• The reporting person is a Director and a 10% Owner, suggesting a significant vested interest in the company's performance.

Negatives

• Substantial dispositions of common shares were made by various entities associated with Mark H. Rachesky, M.D., totaling over 40 million shares across several transactions.
• The complex web of entities and disclaimers of beneficial ownership can obscure the ultimate control and pecuniary interest in the shares.

Risks

• The large volume of share dispositions could indicate a reduction in confidence or a strategic exit from certain positions by a major shareholder.
• The 'continuation fund transaction' might involve complex financial arrangements that could carry inherent risks or uncertainties.
• The existence of Voting and Standstill Agreements with major entities like Liberty Global and Warner Bros. Discovery suggests potential governance complexities and limitations on independent action.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance. However, the nature of the 'continuation fund transaction' implies ongoing strategic adjustments and potential future capital flows related to the managed entities.

Management Comments

• Each of Advisors, MHRC, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such Common Shares except to the extent of their pecuniary interest therein.
• The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Voting and Standstill Agreement... but as to which they have no pecuniary interest.
• The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Governance, Standstill and Voting Agreement... but as to which they have no pecuniary interest.

Industry Context

StockSavvy.ai notes that Form 4 filings from significant shareholders like Directors and 10% Owners are crucial for understanding insider sentiment and potential shifts in strategic holdings within the media and entertainment sector.

Related Party Transactions

• The filing details numerous transactions involving entities managed by MHR Fund Management LLC, where Mark H. Rachesky, M.D. holds significant control or beneficial interest, which constitute related party transactions.

Stakeholder Impact

• Shareholders: The significant volume of share dispositions by a major holder could influence market perception and potentially impact share price, although the context of a continuation fund transaction may mitigate negative sentiment.
• Investment Funds Managed by MHR: The restructuring via a 'continuation fund transaction' directly impacts the investors in these funds, potentially altering their exposure and liquidity.
• Lionsgate Studios Corp.: While not a direct company filing, the actions of a Director and 10% owner can signal strategic shifts or capital management activities that may indirectly affect the company's operations and governance.

Next Steps

• Monitoring future filings to observe any further transactions by Mark H. Rachesky, M.D. and associated entities.
• Analyzing the impact of the 'continuation fund transaction' on the capital structure and operational focus of the involved entities.

Key Dates

Keywords

Lionsgate Studios Corp, LION, Form 4, SEC Filing, Insider Trading, Share Transactions, Mark H. Rachesky, Beneficial Ownership, MHR Fund Management, Continuation Fund Transaction, Director, 10% Owner